In his more than 30 years in healthcare communications, Charlie has held many successful leadership roles both within the pharma industry and communications agencies. Charlie started his career client-side, including global marketing roles for AstraZeneca (neuroscience and oncology) before choosing to transition agency-side in 2001. As Global President of McCann Health Medical Communications since 2005, Charlie has led the development of this business into one of the largest, most capable and best-reputed of its kind with more than 520 Medical Communications specialists worldwide.
In 2016, Charlie took on an expanded role as President of McCann Health EMEA, while retaining responsibilities for Medical Communications globally. In his tenure leading EMEA he led successful growth and development of the region in terms of organization, culture, capability and performance. In 2018, Charlie became President of the McCann Health Global Scientific Council, an important first-of-its-kind initiative designed to develop, connect and mobilize the scientific community within McCann Health and build external partnerships to help make a meaningful difference to human health.
A leader in his field Charlie is an advocate of public-private partnership in healthcare provision, alongside improved industry engagement and transparency in scientific exchange. He is passionate about nurturing a supportive, inclusive environment where talented people can thrive and do their best work in making a meaningful difference for our clients, healthcare professionals and patients. Charlie holds an MBA from Lancaster Management School focused on best practice strategy development and intervening in complex organizations and systems.